Stock Earnings

Question 1

AnaptysBio Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、AnaptysBio Incの総資産は$483で、純lossは$-145です。

Question 2

ANABの主要な財務比率は何ですか？

Accepted Answer

AnaptysBio Incの流動比率は1.17、純利益率は-159.34、1株当たり売上高は$3.2です。

Question 3

AnaptysBio Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

AnaptysBio Inc largest revenue segment is GSK - Royalty - Jemperli, at a revenue of 47,381,000 in the most earnings release.For geography, United States and Australia is the primary market for AnaptysBio Inc, at a revenue of 91,280,000.

Question 4

AnaptysBio Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、AnaptysBio Incの純lossは$-145です。

Question 5

AnaptysBio Incに負債はありますか？

Accepted Answer

yes、AnaptysBio Incの負債は412です。

Question 6

AnaptysBio Incの発行済株式数は何株ですか？

Accepted Answer

AnaptysBio Incの総発行済株式数は30.47株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	169	91	17	10	63	75
Revenue Growth (YoY)	196%	434.99%	70%	-84%	-16%	838%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	45	42	41	36	21	18
Research & Development	153	163	132	88	98	80
Operating Expenses	198	206	174	125	119	98
Other Non Operating Income (Expenses)	-72	-50	-18	-21	-1	0
Pretax Income	-84	-145	-163	-128	-57	-19
Income Tax Expense	0	0	0	0	0	0
Net Income	-84	-145	-163	-128	-57	-19
Net Income Growth	-49%	-11%	27%	125%	200%	-80%
Shares Outstanding (Diluted)	29.01	28.38	26.92	28.17	27.43	27.3
Shares Change (YoY)	0%	5%	-4%	3%	0%	1%
EPS (Diluted)	-2.91	-5.11	-6.07	-4.57	-2.11	-0.73
EPS Growth	-49%	-16%	33%	117%	189%	-80%
Free Cash Flow	-145	-135	-121	-73	-47	-14
Free Cash Flow Per Share	-4.99	-4.75	-4.49	-2.59	-1.71	-0.51
Gross Margin	--	--	--	--	--	--
Operating Margin	-16.56%	-125.27%	-923.52%	-1,150%	-88.88%	-30.66%
Profit Margin	-49.7%	-159.34%	-958.82%	-1,280%	-90.47%	-25.33%
Free Cash Flow Margin	-85.79%	-148.35%	-711.76%	-730%	-74.6%	-18.66%
EBITDA	-28	-114	-157	-115	-56	-23
EBITDA Margin	-16.56%	-125.27%	-923.52%	-1,150%	-88.88%	-30.66%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-28	-114	-157	-115	-56	-23
EBIT Margin	-16.56%	-125.27%	-923.52%	-1,150%	-88.88%	-30.66%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

AnaptysBio Inc (ANAB) Price

ANAB Stock Price Chart

ANAB Income

Follow-Up Questions